Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management.

Selvaskandan, Haresh; Shi, Sufang; Twaij, Sara; Cheung, Chee Kay; Barratt, Jonathan

Selvaskandan, Haresh; Shi, Sufang; Twaij, Sara; Cheung, Chee Kay; Barratt, Jonathan.

Affiliation

Selvaskandan H; Mayer IgA Nephropathy Laboratories, Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
Shi S; Mayer IgA Nephropathy Laboratories, Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
Twaij S; Mayer IgA Nephropathy Laboratories, Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
Cheung CK; Mayer IgA Nephropathy Laboratories, Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
Barratt J; Mayer IgA Nephropathy Laboratories, Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.

Front Immunol ; 11: 572754, 2020.

Article in En | MEDLINE | ID: mdl-33123151

Subject(s)

Biomarkers/metabolism; Glomerulonephritis, IGA/immunology; Monitoring, Immunologic/methods; Clinical Trials as Topic; Disease Management; Humans; Immunity; Practice Guidelines as Topic; Precision Medicine; Risk

Key words

Berger's disease; IgA nephropathy; biomarkers; management biomarkers in IgA nephropathy; treatment

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Monitoring, Immunologic / Glomerulonephritis, IGA Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Front Immunol Year: 2020 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google